October should be the big one with Kinsevere in full production.
July might be more than satisfactory too.
Have thought that the last quarter might not have changed profits to any degree (others much more adept at working this sort of thing out than I) so am slightly bemused at recent price strength.
So agree that a minor retrace might be on the cards - associated too with the traditional end of financial year weakness.
Not complaining.
Add to My Watchlist
What is My Watchlist?
